Elekta AB ser. B (EKTAb)

72.50
+2.16(+3.07%)
  • Volume:
    1,346,185
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    71.98 - 73.72
  • Type:Equity
  • Market:Sweden
  • ISIN:SE0000163628
  • S/N:368587640

EKTAb Overview

Prev. Close
70.34
Day's Range
71.98-73.72
Revenue
14.55B
Open
72.58
52 wk Range
62.6-132.35
EPS
3.02
Volume
1,346,185
Market Cap
27.68B
Dividend (Yield)
2.30
(3.27%)
Average Volume (3m)
1,329,264
P/E Ratio
23.29
Beta
0.92
1-Year Change
-40.99%
Shares Outstanding
382,083,120
Next Earnings Date
Aug 25, 2022
What is your sentiment on Elekta B?
or
Market is currently closed. Voting is open during market hours.

Elekta AB ser. B Company Profile

Elekta AB ser. B Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for cancer and brain disorders worldwide. The company offers radiotherapy treatment systems, such as Versa HD, a dose delivery accuracy system; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT. It also provides personalized imaging tools; automation and integration systems; beam shaping solutions; patient positioning and immobilization solutions; and radiotherapy treatment planning systems. In addition, the company offers radiosurgery systems under the Leksell Gamma Knife Icon, Leksell Gamma Knife Perfexion, and Elekta Axesse names; Leksell GammaPlan, a treatment planning software; and Elekta Unity, a magnetic resonance radiation therapy solution. Further, it provides care management software, such as MOSAIQ Radiation Oncology and MOSAIQ Medical Oncology; MOSAIQ IQ Scripts, a workflow automation and customization tool; Patient Engagement, a patient communication tool; MOSAIQ Evaluate, a plan management and dose review solution; MOSAIQ Locate, a stereotactic localization solution; and METRIQ, a cancer registry data management solution. Additionally, the company offers Flexitron, a remote after loading platform; Esteya, an electronic brachytherapy for treating skin cancer; Oncentra Brachy, a treatment planning software; real-time prostate solutions; and gynecological brachytherapy, bronchus and esophagus, breast, prostate, rectum and bladder, and skin applicators, as well as brachytherapy needles and flexible implant tubes. It also provides Leksell Vantage Stereotactic System for neuroimaging and treatment; Leksell Stereotactic System for minimally invasive stereotactic neurosurgery; and proton therapy components. The company was founded in 1972 and is headquartered in Stockholm, Sweden.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyBuyNeutralStrong Sell
Technical IndicatorsStrong BuyBuyStrong BuySellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Sell